- Home
- GOSS vs NEOV Comparison
GOSS vs NEOV Comparison
Compare GOSS & NEOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- NEOV
- Stock Information
- Founded
- GOSS 2015
- NEOV 2018
- Country
- GOSS United States
- NEOV United States
- Employees
- GOSS N/A
- NEOV N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- NEOV Industrial Machinery/Components
- Sector
- GOSS Health Care
- NEOV Miscellaneous
- Exchange
- GOSS Nasdaq
- NEOV Nasdaq
- Market Cap
- GOSS 212.9M
- NEOV 185.8M
- IPO Year
- GOSS 2019
- NEOV N/A
- Fundamental
- Price
- GOSS $0.80
- NEOV $4.49
- Analyst Decision
- GOSS Strong Buy
- NEOV Strong Buy
- Analyst Count
- GOSS 5
- NEOV 1
- Target Price
- GOSS $9.20
- NEOV $7.50
- AVG Volume (30 Days)
- GOSS 2.3M
- NEOV 233.6K
- Earning Date
- GOSS 11-07-2024
- NEOV 02-07-2025
- Dividend Yield
- GOSS N/A
- NEOV N/A
- EPS Growth
- GOSS N/A
- NEOV N/A
- EPS
- GOSS N/A
- NEOV N/A
- Revenue
- GOSS $105,322,000.00
- NEOV $2,471,178.00
- Revenue This Year
- GOSS N/A
- NEOV $85.10
- Revenue Next Year
- GOSS N/A
- NEOV $281.25
- P/E Ratio
- GOSS N/A
- NEOV N/A
- Revenue Growth
- GOSS N/A
- NEOV N/A
- 52 Week Low
- GOSS $0.50
- NEOV $0.63
- 52 Week High
- GOSS $1.60
- NEOV $6.11
- Technical
- Relative Strength Index (RSI)
- GOSS 50.75
- NEOV 45.98
- Support Level
- GOSS $0.83
- NEOV $4.40
- Resistance Level
- GOSS $1.10
- NEOV $5.36
- Average True Range (ATR)
- GOSS 0.08
- NEOV 0.42
- MACD
- GOSS 0.02
- NEOV -0.10
- Stochastic Oscillator
- GOSS 31.66
- NEOV 9.37
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.